福元医药(601089.SH)：盐酸曲唑酮片获得药品注册证书

Core Viewpoint - Fuyuan Pharmaceutical (601089.SH) has received the drug registration certificate for Clomipramine Hydrochloride Tablets (50mg) from the National Medical Products Administration, allowing the production of this medication [1] Group 1: Company Information - The drug Clomipramine Hydrochloride Tablets was developed by Angelini and was first approved for marketing in Italy on October 15, 1971 [1] - This is the first time the original research drug has been approved for marketing in China [1] Group 2: Industry Context - Clomipramine is indicated for the treatment of depression and is effective for patients with or without anxiety [1]